卡美珠单抗联合白蛋白结合紫杉醇治疗一线驱动因子PS≤2阴性的晚期非小细胞肺癌

{"title":"卡美珠单抗联合白蛋白结合紫杉醇治疗一线驱动因子PS≤2阴性的晚期非小细胞肺癌","authors":"Juan Fu, Shasha Zhu, Jinling Bi, Lu Ding, Ruihua Hu","doi":"10.23736/S2724-5691.24.10382-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":29847,"journal":{"name":"Minerva Surgery","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Carmezumab combined with albumin-bound paclitaxel in the treatment of advanced non-small cell lung cancer with first-line driver PS≤2 negative.\",\"authors\":\"Juan Fu, Shasha Zhu, Jinling Bi, Lu Ding, Ruihua Hu\",\"doi\":\"10.23736/S2724-5691.24.10382-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":29847,\"journal\":{\"name\":\"Minerva Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.23736/S2724-5691.24.10382-6\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S2724-5691.24.10382-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}